Zhenguo Cheng
Zhengzhou, 450052, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Development of Oncolytic Virus-Proteolysis-Targeting Chimera Conjugates for Tumor Immunotherapy.
Journal: ACS nano
Published: December 11, 2025
Pristimerin Alleviates Nanoparticulate Titanium Dioxide-Triggered Neurodegeneration in Hippocampal and Cortex by Downregulation of Inflammation and Oxidative Damage.
Journal: Biological trace element research
Published: July 20, 2025
Exploring the Causal Links Between Toxoplasma gondii Infection and Risk of Brain Tumors: A Bidirectional Mendelian Randomization Analysis.
Journal: Brain and behavior
Published: July 17, 2025
In Situ Sustained Delivery of Tumor Cell-Derived Extracellular Nanovesicles With Oncolytic Adenoviruses for Potentiating Cancer Immunotherapy.
Journal: Journal of extracellular vesicles
Published: June 04, 2025
Bispecific Nanosystems Enable Multieffector Immune Cell Retargeting for Hematologic Malignancy Therapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 23, 2025
Oncolytic adenovirus type 11-induced ferroptosis of esophageal squamous cell carcinoma cells involves in mitochondrial impairment and the mTOR pathway.
Journal: BMC cancer
Published: February 03, 2025
An inhalable microbe-oncolytic virus consortium for lung cancer treatment.
Journal: Cell reports. Medicine
Published: January 24, 2025
MFAP2 promotes the progress of esophageal squamous cell carcinoma by enhancing PTGS2 signaling.
Journal: Journal of Cancer
Published: November 09, 2024
Last Updated: 09/26/2026